Back to sessions
Sep 30
Education

EDU 52 - To Radiate or Not Radiate? Updates to Management of Retroperitoneal Sarcoma

Room 160
04:00pm - 05:00pm PT
Sarcoma and Cutaneous Tumors

MODERATOR(S)

Miranda Lam, MD, MBA - Brigham and Women's / Dana-Farber Cancer Institute

session DESCRIPTION

Retroperitoneal sarcomas (RPS), a rare subset of soft tissue sarcomas, account for 10-15% of these cases and are distinguished by their substantial size, infiltrative nature, and proximity to vital anatomical structures. These characteristics frequently lead to surgical challenges, contributing to high rates of local recurrence and a 5-year overall survival rate of only 50-60%. The STRASS 1 trial has sparked renewed debate regarding the role of preoperative radiation therapy (RT) in treating RPS, resulting in variable application of preop RT across practices. This session aims to provide a comprehensive update on the latest evidence and guidelines for RPS management. Participants will benefit from case-based discussions of various histologic subtype of RPS led by expert surgical and radiation oncologists, gaining insights into the application of preoperative RT and surgical techniques.

learning objectives

  1. Explain the diagnosis, natural history, work up, management options, and outcomes for patients with RPS.
  2. Analyze recently published literature, including recent data and findings from the STRASS trial, to assess the role and impact of preoperative radiation therapy in managing RPS.
  3. Discuss multidisciplinary treatment options to optimize patient outcomes and reduce local recurrence rates in RPS cases.

Credits

AMA PRA Category 1 Credits: 1.00
CAMPEP Credits: 1.00
MDCB Credits: 1.00
EVALUATION

Presentations